You are here: Industry Insights > Veklury

News List

Flamma Continues Veklury Partnership with Gilead for Covid-19 americanpharmaceuticalreview
November 16, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury® (remdesivir) supply chain.
Flamma, Gilead Continue Mfg. Partnership for Veklury contractpharma
November 09, 2020
Flamma will continue to use its sites in Italy and China to support Gilead's network of manufacturers contributing to supply of Veklury.
Gilead gets USFDA approval for Veklury (remdesivir) to treat COVID-19 expresspharma
October 26, 2020
Gilead Sciences announced that the US Food and Drug Administration (FDA) has approved the antiviral drug Veklury (remdesivir) for the treatment of patients with COVID-19 requiring hospitalisation.
FDA approves first treatment for COVID-19 worldpharmanews
October 23, 2020
The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitali
EC signs agreement for additional doses of Gilead’s Covid-19 drug pharmaceutical-technology
October 10, 2020
The European Commission (EC) has inked a joint procurement agreement (JPA) with Gilead Sciences for the supply of up to 500,000 treatment courses of the company’s Covid-19 drug, Veklury (remdesivir).
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury (remdesivir) for the Treatment of COVID-19 drugs.com
September 23, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury (remdesivir)...
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury (remdesivir) for the Treatment of COVID-19 drugs.com
September 23, 2020
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Veklury (remdesivir)...
FDA expands emergency use authorisation for remdesivir to treat all COVID-19 patients europeanpharmaceuticalreview
September 02, 2020
The FDA has expanded the Emergency Use Authorisation for Veklury (remdesivir) to treat all hospitalised patients with COVID-19.
FDA Broadens EUA for Remdesivir for COVID-19 americanpharmaceuticalreview
September 01, 2020
The U.S. Food and Drug Administration (FDA) has broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or ...
FDA grants EUA for Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
September 01, 2020
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Gilead Sciences’ Veklury (remdesivir) to treat all hospitalised patients with Covid-19.

Previous page 1 2 3 Next page